April 7, 2023International Journal of Surgery142 citationsOpen Access

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

YYYichuan YuanCentral University of Finance and Economics WHWei HeGuangdong Provincial Hospital of Traditional Chinese Medicine ZYZhiwen YangSouthwest University of Science and Technology

Key Points

Key points are not available for this paper at this time.

Abstract

Compared with TACE alone, combination therapy was safe enough and resulted in survival benefits. This is a promising treatment option for HCC patients with PVTT.

Perguntar à IA

Bookmark

View Full Paper